SCHEMBL17350097

SCHEMBL17350097

COc1ccc(C)c(Oc2ccc(NC(=O)[C@@H](C)N)cc2)c1.COc1ccc(C)c(Oc2ccc(NC(=O)[C@@H](C)NC(=O)OC(C)(C)C)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
XIAP P98170 1/20 0.46
MMP8 P22894 2/20 0.43
MMP3 P08254 1/20 0.43
MTNR1B P49286 1/20 0.43
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
JAK2 O60674 1/20 0.42
SUV39H2 Q9H5I1 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HDAC8 Q9BY41 1/20 0.38
ABCB1 P08183 1/20 0.38
LTA4H P09960 1/20 0.38
CARM1 Q86X55 1/20 0.37
PRMT6 Q96LA8 1/20 0.37
WDR5 P61964 1/20 0.37
HTT P42858 1/20 0.37
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12594158 0.95 MTNR1B (0.46) MMP8MMP3MTNR1BKDM4EALDH1A1
SCHEMBL12593803 0.87 MTNR1B (0.46) MMP8MMP3MTNR1BKDM4EALDH1A1
SCHEMBL1978265 0.87 XIAP (0.58) XIAPMTNR1BLTA4HCARM1PRMT6
SCHEMBL12595048 0.83 ALDH1A1 (0.43) MMP8MMP3KDM4EALDH1A1HPGD
SCHEMBL1979299 0.82 MTNR1B (0.52) XIAPMTNR1BMEN1KMT2AHTT
SCHEMBL13832500 0.81 MTNR1B (0.67) MMP8MMP3MTNR1BKDM4EALDH1A1
SCHEMBL13268398 0.80 SMN1; SMN2 (0.46) MTNR1BALDH1A1HPGDMEN1KMT2A
SCHEMBL13721585 0.79 XIAP (0.46) XIAPMMP8MMP3MTNR1BMEN1
SCHEMBL17350075 0.78 JAK2 (0.42) XIAPALDH1A1JAK2SUV39H2MEN1
SCHEMBL1978552 0.78 XIAP (0.55) XIAPMTNR1BMEN1KMT2ALTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10058551-B2 Imidazolidinedione derivatives AUTIFONY THERAPEUTICS LIMITED (GB) 2018-08-28 US disclosed
US-20180021336-A1 IMIDAZOLIDINEDIONE DERIVATIVES AUTIFONY THERAPEUTICS LIMITED (GB) 2018-01-25 US disclosed
US-9849131-B2 Imidazolidinedione derivatives AUTIFONY THERAPEUTICS LIMITED (GB) 2017-12-26 US disclosed
US-20170065585-A1 IMIDAZOLIDINEDIONE DERIVATIVES GLAXO GROUP LIMITED (GB) 2017-03-09 US disclosed
EP-2509961-B1 IMIDAZOLIDINEDIONE DERIVATIVES AUTIFONY THERAPEUTICS LTD (GB) 2016-03-09 EP disclosed
US-20160058737-A1 IMIDAZOLIDINEDIONE DERIVATIVES AUTIFONY THERAPEUTICS LIMITED (GB) 2016-03-03 US disclosed
US-9216967-B2 Imidazolidinedione derivatives AUTIFONY THERAPEUTICS LIMITED (GB) 2015-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180021336-A1 IMIDAZOLIDINEDIONE DERIVATIVES KCND3, KCNK3, KCNA3 XIAP 4696/4885MMP8 4831/4885MMP3 1698/4885
US-20170065585-A1 IMIDAZOLIDINEDIONE DERIVATIVES KCND3, KCNK3, KCNA3 XIAP 4696/4885MMP8 4831/4885MMP3 1698/4885
US-20160058737-A1 IMIDAZOLIDINEDIONE DERIVATIVES KCND3, KCNK3, KCNA3 XIAP 4696/4885MMP8 4831/4885MMP3 1698/4885
US-10058551-B2 Imidazolidinedione derivatives KCND3, KCNK3, KCNA3 XIAP 4696/4885MMP8 4831/4885MMP3 1698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.